Works matching DE "LINAGLIPTIN"

Results: 127
    1
    2
    3
    4
    5
    6
    7

    Which is better, high‐dose metformin monotherapy or low‐dose metformin/linagliptin combination therapy, in improving glycemic variability in type 2 diabetes patients with insufficient glycemic control despite low‐dose metformin monotherapy? A randomized, cross‐over, continuous glucose monitoring‐based pilot study

    Published in:
    Journal of Diabetes Investigation, 2019, v. 10, n. 3, p. 714, doi. 10.1111/jdi.12922
    By:
    • Takahashi, Hiroshi;
    • Nishimura, Rimei;
    • Tsujino, Daisuke;
    • Utsunomiya, Kazunori
    Publication type:
    Article
    8

    Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial.

    Published in:
    Journal of Diabetes Investigation, 2018, v. 9, n. 3, p. 579, doi. 10.1111/jdi.12746
    By:
    • Ma, Ronald C. W.;
    • Del Prato, Stefano;
    • Gallwitz, Baptist;
    • Shivane, Vyankatesh K.;
    • Lewis‐d'agostino, Diane;
    • Bailes, Zelie;
    • Patel, Sanjay;
    • Lee, Jisoo;
    • Von Eynatten, Maximilian;
    • Di Domenico, Maximiliano;
    • Ross, Stuart A.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-88108-8
    By:
    • Alvarez-Canales, Mildred Fátima de la Luz;
    • Salazar-López, Sara Stephania;
    • Farfán-Vázquez, Diana;
    • Martínez-López, Yosceline Estrella;
    • González-Mena, Jessica Noemí;
    • Jiménez-Ceja, Lilia Marisela;
    • Vargas-Ortiz, Katya;
    • Evia-Viscarra, María Lola;
    • Montes de Oca-Loyola, María Luisa;
    • Folli, Franco;
    • Aguilar-García, Alberto;
    • Guardado-Mendoza, Rodolfo
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.

    Published in:
    Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01046-z
    By:
    • Awal, Hassan B.;
    • Nandula, Seshagiri Rao;
    • Domingues, Cleyton C.;
    • Dore, Fiona J.;
    • Kundu, Nabanita;
    • Brichacek, Beda;
    • Fakhri, Mona;
    • Elzarki, Adrian;
    • Ahmadi, Neeki;
    • Safai, Shauna;
    • Fosso, Magan;
    • Amdur, Richard L.;
    • Sen, Sabyasachi
    Publication type:
    Article
    37
    38
    39

    Fixed-dose Combination of Dapagliflozin and Linagliptin in Individuals with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: A Randomized Double-blind Multicenter Trial.

    Published in:
    Journal of Diabetology: Official Journal of Diabetes in Asia Study Group, 2025, v. 16, n. 1, p. 50, doi. 10.4103/jod.jod_169_24
    By:
    • Kumthekar, Prashant;
    • Upadhyay, Mihir R.;
    • Tamma, Rajasekhara Reddy;
    • Kranti, Vijay;
    • Bhattacharya, Raja;
    • Sharma, Prabhat Kumar;
    • Barge, Vijaykumar Bhagwan;
    • Revankar, Santosh;
    • Ghatge, Shweta
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50